MB-EAT rescue test for health education group

Phase 2

Recruiting

• Conditions: Obesity

• Registration Number: JPRN-jRCT1033210709
• Lead Sponsor: Ono Hiraku

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

1)Primary diagnosis of Obesity with a BMI of 30 or higher .
2)The age between 18 to 65.
3)Patients with full consent of participation in the study.
4)Possible to communicate in Japanese.
5)Patients who have an internet environment at home and have a personal computer or tablet device.
6)No addition of weight loss drug or appetite suppressant during the study.
7)Possible to understand Mindfulness-Based Eating Awareness Training and have mental and physical.
8)If Ovesity is primary diagnosed, patients with Depressive Disorder and Anxiety Disorder will not be excluded from the study.
9)Patients who agree not to use weight loss drugs (Sanorex) or Diabetes drug (Ozempic) for about 6 months until the end of the study.
10)Patients who agree not to undergo Bariatric surgery for about 6 months until the end of the study.
11)Those who consent to contraception with their partner while undergoing mindfulness dietary meditation training for safety for approximately 6 months until the end of this study.

Exclusion Criteria

1)Pregnant,lactating or less than 6 months after giving birth.
2)Patients who taking weight loss drugs or Diabetes drug (Ozempic) .
3)Patinets who plan undergo Bariatric surgery.
4)Patients who have Organic brain disorder ( including Dementia), Psychosis, Substance abuse or dependence, other severemental disorders.
5)Active suicidality.
6)Repetitive anti-social behavior.
7)Severe physical condition.
8)Those who have mental retardation (refer to the evaluation scores such as JART-25: Japanese Adult Reading Test-25) and those who have autism spectrum disorder (AQ: refer to the autism spectrum index etc.).
9)Patients who cannot contact with the study organizer.
10)Other relevant reason decided by the investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified